ArticleBritish journal of sports medicine2025
Association between frequency of meeting daily step thresholds and all-cause mortality and cardiovascular disease in older women.
Article in British journal of sports medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveTo examine the associations between the number of days per week achieving various daily step thresholds and all-cause mortality and cardiovascular disease (CVD) incidence in older women.
methodsWe conducted a prospective cohort study of 13 547 women free of CVD and cancer (mean age 71.8 years). We included participants who wore an ActiGraph GT3X+ accelerometer for 7 consecutive days between 2011-2015 and were subsequently followed for mortality through 2024. Women were classified by the number of days per week achieving step thresholds of ≥4000, ≥5000, ≥6000 or ≥7000 steps/day. Cox proportional hazards regression estimated hazard ratios (HR) and 95% confidence intervals (95% CI) for all-cause mortality and CVD incidence, adjusting for lifestyle behaviours and comorbidities.
resultsDuring a median follow-up of 10.9 years, 1765 women (13.0%) died and 781 (5.1%) developed CVD. Achieving ≥4000 steps/day on 1-2 and ≥3 days/week was associated with lower mortality risk compared with 0 days/week (adjusted HR 0.74 (95% CI 0.65 to 0.86) and 0.60 (95% CI 0.53 to 0.68), respectively). For CVD, corresponding results were 0.73 (95% CI 0.58 to 0.92) and 0.73 (95% CI 60 to 0.89), respectively. An inverse curvilinear dose-response relationship was observed for mortality, such that with higher step thresholds (5000, 6000 or 7000), the risk of mortality further declined modestly. With additional adjustment for mean daily steps, associations were attenuated to the null.
conclusionsAmong older women, achieving ≥4000 steps/day on even 1-2 days/week was associated with lower mortality and CVD, while more steps were associated with even better outcomes. A greater number of steps, regardless of daily patterns, is associated with better health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.